Patching adherence is linked to improved grating visual acuity

Article

Patching during the first six months after surgery is linked to improved grating visual acuity in infants with unilateral cataract.

Patching during the first six months after surgery is linked to improved grating visual acuity in infants with unilateral cataract, reveals a paper in Investigative Ophthalmology & Visual Science.

Dr Carolyn D. Drews-Botsch et al., Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA, completed a randomized clinical trial of 108 infants with unilateral congenital cataract.

Patching was conducted one hour per day every month until the patient was eight months of age. The mean percentage of prescribed patching was used to measure adherence in a weeklong diary completed two months postoperatively. Recall interviews lasting 48 hours were also performed three and six months postoperatively.

Teller Acuity Cards were used to measure grating visual acuity within one month of the infant's first birthday. The link between grating acuity and patching was found with nonparametric correlations.

The results revealed that 84.3% of prescribed time and adherence did not change according to treatment. Adherence was found to be strongly associated with grating acuity, especially among pseudophakic patients compared to aphakic infants. Implanting an intraocular lens (IOL) was not linked to adherence.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.